- Home
- MX vs STRO Comparison
MX vs STRO Comparison
Compare MX & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MX | STRO |
|---|---|---|
| Founded | 2003 | 2003 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.8M | 94.9M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | MX | STRO |
|---|---|---|
| Price | $2.91 | $8.00 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 7 |
| Target Price | ★ $5.75 | $1.97 |
| AVG Volume (30 Days) | ★ 583.4K | 93.1K |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $224,755,000.00 | $105,646,000.00 |
| Revenue This Year | N/A | $65.48 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.62 | N/A |
| 52 Week Low | $2.18 | $5.23 |
| 52 Week High | $5.16 | $30.10 |
Technical Indicators
Market Signals| Indicator | MX | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 65.83 | 95.42 |
| Support Level | $2.19 | $0.72 |
| Resistance Level | $2.43 | $0.94 |
| Average True Range (ATR) | 0.15 | 0.20 |
| MACD | 0.09 | 0.49 |
| Stochastic Oscillator | 100.00 | 97.44 |
Price Performance
Historical ComparisonAbout MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely, Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.